I'm researching this now. It may take time to get letter together as so busy for a week or so.
Got this reply from my surgery today. Sharing for info (and to give you a laugh). The first sentence made me choke on my cornflakes! Yes of course I'm joking......I wasnt choking ;-)
We have recently had correspondence regarding BM machines.
The following is the information the CCG meds management team have sent
“Self-monitoring of blood glucose (SMBG) is of limited clinical effectiveness in improving blood glucose control in patients with Type 2 Diabetes Mellitus (T2DM) on oral therapies or diet control and therefore is unlikely to be cost effective.
SMBG in T2DM is usually advised where a patient:
· is on insulin or
· there is evidence of hypoglycaemia or
· the person is on oral medication that may increase their risk of hypoglycaemia (while driving/operating machinery)
· or the person is pregnant, or is planning to become pregnant,
and the patient has an understanding of the benefits of monitoring and how to interpret the results i.e. reinforce lifestyle changes or adjust therapy accordingly.
Patients who gain no clinical benefit from SMBG should be discouraged from testing.
Prescribing of BGTS should be reviewed to ensure that testing is appropriate. IF test strips are indicated, quantities & frequency of issue should be reviewed to avoid wastage. Please see LMMG guidance for frequency of monitoring & appropriate quantities to supply
https://www.lancsmmg.nhs.uk/downloa...lucose-Testing-Guidance-V1.1-FOR-WEBSITE2.pdf
Please also find attached up to date data for the prescribing of test strips in patients with T2DM who do not appear to be prescribed insulin, a sulphonylurea or a glinide.
Kind regards
Medicines Optimisation Team”
Hope this is useful information.
Best wishes,